Comparison of Predicted Cardiovascular Risk Profiles by Different CVD Risk-Scoring Algorithms between HIV-1-Infected and Uninfected Adults: A Cross-Sectional Study in Tanzania.

HIV/AIDS : Research and Palliative Care
Titus MsokaMichiel van Agtmael

Abstract

Cardiovascular disease (CVD) risk assessment is a suitable way to differentiate between high-risk individuals requiring intervention and risk modification, and those at low risk. However, concerns have been raised when adopting a CVD-risk prediction algorithm for HIV-infected patients in sub-Saharan Africa. We compared cardiovascular risk profiles between HIV-infected (with and without antiretroviral therapy (ART)) and HIV-uninfected adults as predicted by the American College of Cardiology/American Heart Association (ASCVD) and the Framingham cardiovascular risk score (FRS) algorithms and assessed the concordance of the algorithms in predicting 10-year CVD risk separately in HIV-infected and uninfected groups in a hospital-based cross-sectional study in Tanzania. A cross-sectional hospital-based study including 40 HIV-infected ART-naive, 64 HIV-infected on ART, and 50 HIV-uninfected adults was conducted. Traditional cardiovascular risk factors were determined by standard investigations. The primary outcome was the absolute 10-year CVD risk score based on the two algorithms. Compared to HIV-uninfected, HIV-infected adults were classified at a higher 10-year CVD risk. ASCVD algorithms predicted a higher proportion of high-risk i...Continue Reading

References

Jan 1, 1991·American Heart Journal·K M AndersonW B Kannel
Nov 6, 1998·Statistical Methods in Medical Research·P E Shrout
Aug 10, 2001·American Journal of Epidemiology·J S Kaufman, R S Cooper
Aug 24, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B M BergersenS Tonstad
Aug 19, 2007·Scandinavian Journal of Infectious Diseases·Giuseppe Vittorio L De SocioGiuseppe Schillaci
Sep 11, 2007·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Susan E MacDonaldGraeme Smith
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Feb 19, 2008·QJM : Monthly Journal of the Association of Physicians·J E Naschitz, R Lenger
Dec 18, 2012·International Journal of Clinical Practice·L KakinamiS G Fisher
Aug 24, 2013·Scandinavian Journal of Infectious Diseases·Sun Bean KimJune Myung Kim
Jun 24, 2015·Critical Pathways in Cardiology·Juan Carlos Bazo-AlvarezUNKNOWN PERU MIGRANT Study; CRONICAS Cohort Study Group
May 18, 2016·BMJ : British Medical Journal·Johanna A A G DamenKarel G M Moons
Jun 14, 2016·Journal of Racial and Ethnic Health Disparities·Irma B AnchetaLatha Palaniappan
Jun 28, 2016·The Pan African Medical Journal·Ifeyinwa Dorothy OsegbeElaine Chinyere Azinge
Jul 22, 2017·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Lauro Ferreira da Silva Pinto NetoCarolina Rocio Oliveira Santos
Feb 7, 2018·International Journal of Cardiology·Daniel BoatengKerstin Klipstein-Grobusch
Feb 16, 2018·Circulation·Virginia A TriantRalph B D'Agostino
May 17, 2018·Journal of General Internal Medicine·Jessica K PaulusDavid M Kent
Sep 17, 2019·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Sara PolicarpoEmília Valadas
Oct 2, 2019·Vascular Health and Risk Management·Vibha BhatnagarMichael Galarneau

❮ Previous
Next ❯

Software Mentioned

StatCalc
Statistical Package for Social Sciences ( SPSS
Epi Info
OneTouch
ASCVD

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.